Navigation Links
AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
Date:6/17/2009

TUSTIN, Calif., June 17 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today its Chairman and CEO Mr. Douglas MacLellan has been featured in CEOCFO Magazine - a daily online investment news publication that delivers market news and analysis to investors through exclusive interviews with venture capital and publicly-traded companies listed on US and International stock exchanges.

In his interview Mr. MacLellan comments on AMDL's continued focus to become a leading pharmaceutical company with three distinct and growing divisions that include In Vitro Diagnostics (IVD), High End Skin Care Products, and China-based Pharmaceuticals; and target goals of achieving profitability across AMDL's US and China-based operations by year end.

Mr. MacLellan also provided updates on AMDL's worldwide commercialization strategy for the Company's DR-70 (FDP) IVD cancer test saying, "We are leveraging last year's US FDA approval for DR-70 with the launch of an international commercialization and have already realized sales revenues in this division. I believe in vitro diagnostics will be a substantial segment for the AMDL -- one that absolutely has the potential to generate equivalent or better returns as compared to our China-based pharmaceutical division."

Since 2006 AMDL has achieved more than 100% in year-over-year gross revenue growth and remains on track with its FY2009 business milestones and financial guidance projections. The Company is featured as the "#1 Small-Cap Stock Pick for 2009" by Flaherty Financial News (www.flahertyfinancialnews.com ), a New York-based investment newsletter, and was named one of the Top 5 fastest growing publicly-traded companies in Orange County by intern
'/>"/>

SOURCE AMDL Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
2. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
4. Allscripts Featured in Microsoft HealthVault Worldwide Launch
5. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
6. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
7. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
8. Morris Animal Foundation Featured on NASCAR Racecar to Raise Awareness of Pet Cancer
9. Effective Treatment for Fibromyalgia Featured on Oprah Winfrey Show You Dont Have to Live With That Agony!
10. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
11. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...s were more likely to consider change after 30-min... , FRIDAY, Nov. 27 (HealthDay News) -- A progr...why they should stop their dangerous behavior may ...archers have found. , The new study included 18...aired convictions, who were randomly assigned to o...
(Date:11/27/2009)...WNA, BC, Nov. 27 /PRNewswire/ - Uploadable USB ped...me time in wellness. A combination of advanced acc... are solving a long term concern over the accuracy...ately gauge and reward improved participation in a... one of the first wellness suppliers to integrate ...
(Date:11/27/2009)...HESTER, N.Y., Nov. 27 P... provider and fortunately every year, new vaccines...But do all vaccines boost immunity for the same pe...oster shots, needed to keep immunity strong? ,...l of the American Academy of Pediatrics, Michael P...
(Date:11/27/2009)...ling plus low-emission vehicles may reduce future ...AY, Nov. 27 (HealthDay News) -- Encouraging city d...would offer much greater public health benefits th...esearchers have found. , The study compared the...rban land transport scenarios for London, England,...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
..., Safety and Efficacy Study of Zolpidem Tartrate S...wakening on an As-Needed Basis , , Evaluation of ...sive Compulsive Disorder , , RICHMOND, Calif., Ma...etary products that address important therapeutic ...
..., Videotape The Silliest Sneeze You,ve Ever Seen F...Little Allergies(R) Allergen Block! , , Contest E....Y., May 21 Do your friends, family, or coworkers...Allergen Block , announce the launch of the first ...
...Procedure doubles odds for intensive care compared... , THURSDAY, May 21 (HealthDay News) -- Babies...livery are nearly twice as likely to be admitted t...ion babies are also more likely to have breathing ...
..., LAS VEGAS, May 21 CPC of America, Inc. (OTC Bul...of its first patent of a synthetic sealant for spe... focused on the development and testing of the Med...on, CPC is focused on the development of its own s...
..., PRINCETON, N.J., May 21 Celator Pharmaceuticals...ch agreement with Cephalon, Inc. (Nasdaq: CEPH )...tion of the application of Celator,s proprietary t...echnology and expertise at Celator beyond our own ...
..., - Bold and innovative marketing campaign will ta...of use and excellent tolerability - , , CORONA, C...in generic and specialty branded pharmaceuticals, ...h symptoms of urge urinary incontinence, urgency, ...
Other Medicine News:Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:If Heads Turn When You Sneeze, Enter the 'Side-Splitting Sneeze Contest' 2Health News:Risk to Baby Rises With Repeat C-Sections 2Health News:Risk to Baby Rises With Repeat C-Sections 3Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 3Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 4
(Date:11/25/2009)... , NEW YORK, Nov. 25 R...ch report is available in its catalogue: ,, Un...ecasts to 2015 ,, http://www.reportlinker.com...ysis-and-Forecasts-to-2015.html ,, United Stat... 2015 ,, Summary ,, This report is an esse...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewsw...ufacturer of direct digital Radiography ( ddR ) sy...en acquired by a private Swiss Investor with a lon...ging brand. The acquisition included all assets an...inventory. After 25 years of success and growth Sw...
(Date:11/25/2009)... , CHAPEL HILL, N.C., Nov. 25 /PRNewswir...that Prabhavathi Fernandes, president and chief ex... 21st Annual Health Care Conference at 8:50 a.m. E... in New York City. Dr. Fernandes will provide an ...linical programs for the treatment of drug-resista...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2Americans United for Life Action Says the House Approved Bill to Promote Abortion Overseas is a Grave Injustice 48545 1Scientists advance safety of nanotechnology 48543 1Scientists advance safety of nanotechnology 48543 2Scientists advance safety of nanotechnology 48543 3Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 1Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 3Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 4Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 5Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 6
...n-free results compared to,sumatriptan, RESEARCH T...,/PRNewswire-FirstCall/ -- -- Findings from two pi... sufferers demonstrated that,Trexima(TM) provided ...rs compared to placebo, and two through 24-hour su...proxen monotherapy. The,results were published tod...
...mmune, a,clinical stage nanomedicine company focus...tifunctional, tumor-targeted therapies has,been se...erican,Society of Clinical Oncology Annual Meeting... will take place from 8:00 am to 12,noon on June 3...sent the poster abstract entitled "Preliminary Res...
Other Medicine Technology:Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 2Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 3Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 4Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 5CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2
Reusable Template
MicroTouch LP (Low Profile) Stabilizer
Precision Stepper
SurePoint™ Stepper/Stabilizer EquipmentTable Mount
Medicine Products: